No evidence for the benefit of PPIs in the treatment of acute pancreatitis: a systematic review and meta-analysis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 02 2023
16 02 2023
Historique:
received:
31
10
2022
accepted:
13
02
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
22
2
2023
Statut:
epublish
Résumé
Although current guidelines do not recommend the use of proton pump inhibitors (PPIs) in the standard of care of acute pancreatitis (AP), they are often prescribed in clinical practice, mainly for ulcer stress prophylaxis. In this systematic review and meta-analysis we evaluated the association between the use of PPIs in the management of AP and various clinical outcomes. We conducted the systematic research in six databases without restrictions on January 24th, 2022. We investigated adult patient with AP, who were treated with PPI compared to conventional therapy. The pooled odds ratios, mean differences, and corresponding 95% confidence intervals were calculated with random effect model. We included six RCTs and three cohort studies, consisting of 28,834 patients. We found a significant decrease in the rate of pancreatic pseudocyst formation in patients who received PPI treatment. PPI use was associated with a higher risk of GI bleeding, however this finding could be due to the patients' comorbid conditions. We found no significant difference in the rates of 7-day mortality, length of hospital stay, and acute respiratory distress syndrome between the groups. The available data on this topic are limited; therefore, further well designed RCTs are needed to evaluate the potential benefits and adverse effects of PPIs in AP.
Identifiants
pubmed: 36797320
doi: 10.1038/s41598-023-29939-5
pii: 10.1038/s41598-023-29939-5
pmc: PMC9935541
doi:
Substances chimiques
Proton Pump Inhibitors
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2791Informations de copyright
© 2023. The Author(s).
Références
J Natl Cancer Inst. 1959 Apr;22(4):719-48
pubmed: 13655060
Int J Clin Pharmacol Ther. 2005 Dec;43(12):558-61
pubmed: 16372517
Sci Rep. 2021 Dec 17;11(1):24158
pubmed: 34921151
Res Synth Methods. 2010 Apr;1(2):112-25
pubmed: 26061377
Sci Rep. 2020 Nov 18;10(1):20063
pubmed: 33208878
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Turk J Gastroenterol. 2014 Oct;25(5):582-3
pubmed: 25417626
Pancreatology. 2021 May 19;:
pubmed: 34059448
Gastroenterology. 2018 Mar;154(4):1096-1101
pubmed: 29409760
Biomed Pharmacother. 2020 Dec;132:110770
pubmed: 33011613
Pancreatology. 2021 Oct;21(7):1237-1246
pubmed: 34332908
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Res Synth Methods. 2016 Mar;7(1):55-79
pubmed: 26332144
Therap Adv Gastroenterol. 2016 Sep;9(5):671-8
pubmed: 27582879
Am J Ther. 2018 Jul/Aug;25(4):e492-e493
pubmed: 28282309
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Stat Methods Med Res. 2001 Dec;10(6):375-92
pubmed: 11763548
Pancreatology. 2015 Sep-Oct;15(5):491-496
pubmed: 26296720
Gut. 2022 Dec;71(12):2601-2602
pubmed: 35046088
Trop Gastroenterol. 2015 Jan-Mar;36(1):31-5
pubmed: 26591952
Cureus. 2021 Jan 11;13(1):e12624
pubmed: 33585113
Am J Gastroenterol. 2006 Oct;101(10):2379-400
pubmed: 17032204
Ther Drug Monit. 2012 Jun;34(3):242-4
pubmed: 22495426
Am J Ther. 2020 Jul/Aug;27(4):e411-e412
pubmed: 31045878
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Nov;48(6):933-936
pubmed: 29260533
Int J Mol Sci. 2019 Oct 21;20(20):
pubmed: 31640115
J Pediatr Hematol Oncol. 2014 Nov;36(8):660-1
pubmed: 23652874
World J Gastroenterol. 2009 Jan 7;15(1):38-47
pubmed: 19115466
Gastroenterology. 2022 Jan;162(1):122-134
pubmed: 34571026
Gastroenterology. 2020 Nov;159(5):1958-1961.e8
pubmed: 32687926
Front Pharmacol. 2020 Sep 08;11:552102
pubmed: 33013389
Zhonghua Wai Ke Za Zhi. 2021 Jul 1;59(7):578-587
pubmed: 34256457
Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416
pubmed: 23896955
Dig Dis Sci. 2009 Nov;54(11):2312-7
pubmed: 19714466
J Clin Med. 2020 May 19;9(5):
pubmed: 32438747
Korean J Gastroenterol. 2012 Dec;60(6):362-7
pubmed: 23242019
Life Sci. 2010 Oct 23;87(17-18):551-7
pubmed: 20851132
Therap Adv Gastroenterol. 2020 Mar 19;13:1756284820913743
pubmed: 32218806
PLoS One. 2016 Oct 31;11(10):e0165309
pubmed: 27798670
Gastroenterol Res Pract. 2020 Dec 10;2020:2549486
pubmed: 33376482
Nat Med. 2021 Aug;27(8):1317-1319
pubmed: 34312557
BMC Med. 2016 Nov 9;14(1):179
pubmed: 27825371
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
World J Gastroenterol. 2015 Mar 7;21(9):2651-7
pubmed: 25759533
BMC Med Res Methodol. 2014 Feb 18;14:25
pubmed: 24548571
Int J Med Sci. 2021 Jun 16;18(14):3050-3058
pubmed: 34400875
In Vitro Cell Dev Biol Anim. 2007 Jan;43(1):25-7
pubmed: 17570031
World J Gastroenterol. 2016 Dec 28;22(48):10477-10481
pubmed: 28082800
World J Emerg Surg. 2019 Jun 13;14:27
pubmed: 31210778
Pharmacy (Basel). 2018 May 14;6(2):
pubmed: 29757930
Clin Transl Med. 2022 Jun;12(6):e842
pubmed: 35653504
Pancreatology. 2020 Oct;20(7):1323-1331
pubmed: 32948430
J Gastroenterol. 2003;38(11):1025-35
pubmed: 14673718
Stat Med. 2004 May 15;23(9):1351-75
pubmed: 15116347
Stat Med. 2003 Sep 15;22(17):2693-710
pubmed: 12939780
Am J Epidemiol. 1986 Nov;124(5):719-23
pubmed: 3766505
Front Pharmacol. 2021 Dec 14;12:772975
pubmed: 34970144
J Res Natl Bur Stand (1977). 1982 Sep-Oct;87(5):377-385
pubmed: 34566088
Nutrients. 2022 May 20;14(10):
pubmed: 35631272
Therap Adv Gastroenterol. 2018 May 30;11:1756284818777943
pubmed: 29872455
Cochrane Database Syst Rev. 2017 Apr 21;4:CD011384
pubmed: 28431202
Mucosal Immunol. 2017 Mar;10(2):283-298
pubmed: 27848953
PLoS One. 2015 May 18;10(5):e0126432
pubmed: 25993003